AD/PD 2022 View overview page

Mechanisms influencing mitochondrial dysfunction in Alzheimer’s disease

Environmental toxins cause inflammatory response in microglial cells

ADNI: developing biomarkers for Alzheimer’s disease

Lymphatic system as a source of disease-specific biomarkers

Plans to reduce sampling bias in the ADNI project

Solutions to increase enrolment of under-represented minorities in the ADNI

How does the lymphatic system modulate immunity?

The importance of diversifying the ADNI population

Novel probe for selective imaging of tau tangles in human retina

Function of the lymphatic system: fluid volume control, drainage systems & immunosurveillance

iPSC-derived 3D organoid models to explore Alzheimer’s disease

Increasing the expression of Mer receptors in microglia: a potential therapy for Alzheimer’s disease

Mitochondrial defects in Alzheimer’s disease

Inhibition of CXCR4/CXCL12 signaling: a translational perspective for Alzheimer’s disease treatment

Highlights from the AD/PD 2022 conference

Developments on microglia in neuroinflammation: TREM2 upregulation in Alzheimer’s disease